B2iDigital
Posted - 4 hours ago
The team at B2i Digital is pleased to share that our Featured Company, Unicycive Therapeutics (Nasdaq: $UNCY) (https://b2idigital.com/unicycive), a clinical-stage biotechnology company focused on kidney disease, will participate in two investor conferences this December. Upcoming Conferences: NOBLE Capital Markets 20th Annual Emerging Growth Equity Conference https://nobleconference.com/ Date: Tuesday, December 3, 2024 Time: 3:00 PM ET Location: Boca Raton, FL Piper Sandler 36th Annual Healthcare Conference https://www.pipersandler.com/conferences-and-events?sectors=518 Event: Fireside Chat Date: Thursday, December 5, 2024 Time: 12:30 PM ET Location: New York, NY Live and archived webcasts of these events will be available under the Events and Presentations section of Unicycive’s IR website. To schedule a 1-on-1 meeting with management, contact your Noble Capital Markets or Piper Sandler representative. The complete news release about the company’s participation in these two conferences is available at https://ir.unicycive.com/news/detail/90/unicycive-therapeutics-to-participate-in-two-upcoming B2i Digital acknowledges the continued diligence of Dr. Shalabh Gupta, MD and his dedicated management team, including CFO John Townsend, EVP Doug Jermasek, EVP Pramod Gupta, Dr. Atul Khare, Ph.D., M.B.A., and Dr. Guru Reddy, in their mission to address unmet needs in kidney disease treatment. Please visit Unicycive (https://unicycive.com/) and B2i Digital (https://b2idigital.com/) to learn more. #Unicycive #UNCY #B2iDigital #InvestorConference #KidneyDisease #Biotech DISCLAIMER: B2i Digital’s CEO, David Shapiro, owns 60,000 shares of unrestricted UNCY stock as of November 21, 2024. This post is not intended to solicit the sale of UNCY or any security, and it is not intended to offer any opinion on UNCY as an investment. Conduct your own research and consult with your own professional advisors prior to making any investment decisions. See the full disclaimer in the Risks and Disclosures section of https://b2idigital.com/unicycive.
ThisWi11hurt
Posted - 6 hours ago
$NUWE loaded up again 1.21
$TNXP $UNCY $TPST
StockAuthority
Posted - 12 hours ago
$SNSE red to green coming here, these bios tend to dip in am, then run in PM. Who else remembers that with $UNCY as we marched up 150% off bottom? every day, great buys in AM then rips in afternoon.
KING_OF_BIO
Posted - 13 hours ago
$UNCY Chart is looking clear for takeoff - I'm in :)
StockMasterHere
Posted - 17 hours ago
$CDT $0.25 Today, Massive buying by insiders, 5 form 4 filed yesterday after market close. LFG and open at $0.15 $UNCY $SWTX $CTCX
Charli_with_an_I
Posted - 1 day ago
@GREGORYARCHANGEL love it! $mcrb $UNCY and $ALT have been fun today!
DouglasJanes2025
Posted - 1 day ago
$UNCY booooring. Wake me up at $2!
Smesic
Posted - 1 day ago
$UNCY bio stocks are on 🔥 today!
MikeProZ
Posted - 1 day ago
$UNCY Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update
Smesic
Posted - 1 day ago
$SNSE $VISL $UNCY let’s have a great day today! 🙏📈
Mikem239
Posted - 1 day ago
$UNCY I bought 10,000 more at .43. I’m a believer. GLTA
KP81
Posted - 2 days ago
$UNCY look at those curls . daily looking good. Bet we retest .5 and retest .6 gap
SmallCapGrowth
Posted - 2 days ago
$UNCY Unicycive Announces Third - BREAKOUTS..RUNNERS AND HOT PENNIES https://investorshangout.com/post/view?id=6730543 @chazzsheen3
SmallCapGrowth
Posted - 2 days ago
$UNCY Unicycive Therapeutics Announces U.S. FDA Acceptance of the New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis https://finance.yahoo.com/news/unicycive-therapeutics-announces-u-fda-120000040.html @chazzsheen3
SmallCapGrowth
Posted - 2 days ago
BB's Stock Haven : $UNCY announced its financial results fo... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175408653 via @Investors_Hub @chazzsheen3
SmallCapGrowth
Posted - 2 days ago
$UNCY Unicycive Therapeutics Announces U.S. FDA Acceptance of the New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis https://finance.yahoo.com/news/unicycive-therapeutics-announces-u-fda-120000040.html @chazzsheen3
SmallCapGrowth
Posted - 2 days ago
$UNCY Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update https://finance.yahoo.com/news/unicycive-announces-third-quarter-2024-121500882.html @chazzsheen3
DouglasJanes2025
Posted - 2 days ago
$UNCY this is headed for 20 cents by Xmas if nothing impressive is produced before then. I’ve called the SP movement correctly so far, disagree with me at your peril.
Super__Mario
Posted - 2 days ago
$UNCY dead money for the next 4 months
BabyfaceMcD
Posted - 3 days ago
$TNXP surprised to see SP one of my Covid favs 👀 $UNCY panned out chart looks good making notes on this one as well $AZI probably best momentum stock today looks like it will continue to climb
Eliteh
Posted - 3 days ago
$UNCY Anyone know if their $100 M shelf they just filed for, a preparation for the $100M in committed capital for the 3 tranches?
SmallCapGrowth
Posted - 3 days ago
Unicycive Therapeutics, Inc. (Nasdaq: $UNCY): Virtual Investor Conferences https://www.youtube.com/watch?v=Ycz3LAWJ8jk&t=27s